Strategic Partners
InVasc Therapeutics intends to maximize its new product opportunities by leveraging past experience and proven skills in developing and launching new drugs. Core competencies include preclinical and clinical trial design, product development strategies, navigation through regulatory issues, comprehensive knowledge of cardiometabolic market needs and the ability to launch products successfully within the industry, ultimately driving product sales.
We view our suppliers as partners, and with them we are currently acquiring and re-formulating third-party compounds that are in development or are in clinical trials. For INV-144 we have identified cGMP sources of supply with Drug Master Files (DMF) in the appropriate jurisdictions.
InVasc has an exclusive worldwide agreement and co-ownership to intellectual property with Ohio State University to explore a series of compounds we are targeting for the treatment of atherosclerosis and cardiovascular disease.
If your organization is interested in learning more about Invasc Therapeutics and potential product partnership opportunities, please contact us today.
InVasc has an exclusive worldwide agreement and co-ownership to intellectual property with Ohio State University to explore a series of compounds we are targeting for the treatment of atherosclerosis and cardiovascular disease.
